Azitra Advances ATR-04 Trial to Cohort 2 Following Safety Review
Azitra has advanced its ATR-04 drug into Cohort 2 of its Phase 1/2 clinical trial after a safety review committee approved its progression.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Azitra advances ATR-04 trial to Cohort 2
Azitra said its ATR-04 Phase 1/2 clinical trial moved to Cohort 2 after Safety Review Committee clearance.